Nurix Therapeutics (NRIX) Net Equity Issued and Repurchased (2019 - 2026)
Nurix Therapeutics (NRIX) posted Net Equity Issued and Repurchased of $5.16 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 346.7% from $1.16 million a year earlier.
Nurix Therapeutics (NRIX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
For the trailing twelve months through Aug 31, 2026, Net Equity Issued and Repurchased at Nurix Therapeutics was $261.21 million, up 28.6% year-over-year; for FY2025 (ended Nov 30, 2025), it came in at $238.64 million, down 50.9% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Net Equity Issued and Repurchased was $485.68 million in FY2024, $3.22 million in FY2023 (-97.3%), $117.19 million in FY2022 (-23.8%) and $153.88 million in FY2021 (-54.6%).
- Quarterly Net Equity Issued and Repurchased has run from a low of -$135,000 in fiscal Q4 2022 to a high of $237.77 million in fiscal Q2 2024 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last five quarters, with growth averaging 31.5%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was fiscal Q3 2026, with growth of 346.7%; the weakest was fiscal Q2 2025, with a decline of 100.0%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior fiscal quarters was $66,000 (Q2 2026), $19.98 million (Q1 2026) and $236.01 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 5.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 5.16 Mn |
| May 31, 2026 | 66,000.00 |
| Feb 28, 2026 | 19.98 Mn |
| Nov 30, 2025 | 236.01 Mn |
| Aug 31, 2025 | 1.16 Mn |
| May 31, 2025 | 6,000.00 |
| Feb 28, 2025 | 1.47 Mn |
| Nov 30, 2024 | 200.52 Mn |
| Aug 31, 2024 | 45.77 Mn |
| May 31, 2024 | 237.77 Mn |
| Feb 29, 2024 | 1.62 Mn |
| Nov 30, 2023 | 7,000.00 |
| Aug 31, 2023 | 1.70 Mn |
| May 31, 2023 | 25,000.00 |
| Feb 28, 2023 | 1.48 Mn |
| Nov 30, 2022 | -135,000.00 |
| Aug 31, 2022 | 115.41 Mn |
| May 31, 2022 | 432,000.00 |
| Feb 28, 2022 | 1.49 Mn |
| Nov 30, 2021 | 500,000.00 |
Nurix Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();